en.Wedoany.com Reported - Nuclear fuel company Quantum Leap Energy (QLE) has signed a research agreement with the Texas A&M University Engineering Experiment Station (TEES) to advance the commercial production of high-purity uranium hexafluoride (UF6) and reduce technical risks. Uranium hexafluoride is a key feedstock in the existing nuclear fuel enrichment supply chain.
The agreement reflects the growing momentum of the nuclear industry in Texas while highlighting the value of collaboration in strengthening the U.S. domestic nuclear fuel supply chain.
QLE is a subsidiary of ASP Isotopes (ASPI), an advanced materials and isotope enrichment company listed on the Johannesburg Stock Exchange and Nasdaq. QLE focuses on advancing innovative technologies and processes in critical segments of the fission and fusion nuclear fuel cycles.
Dr. Ryno Pretorius, CEO of QLE, stated that this collaboration is a significant step toward building a more resilient and scalable nuclear fuel supply chain. He noted that uranium conversion is a critical step in the nuclear fuel cycle, transforming yellowcake into uranium hexafluoride, the feedstock required for uranium enrichment. With only one operational commercial conversion facility currently in the United States, expanding domestic conversion capacity is essential to strengthening energy security and reducing dependence on foreign sources.
Through its partnership with TEES, QLE is advancing technologies aimed at improving production efficiency, reducing costs, and supporting the growing demand for nuclear fuel. Dr. Pretorius said the goal is to lay the foundation for a safe and commercially viable nuclear fuel cycle.
Dr. Lin Shao, Associate Agency Director of TEES and Professor of Nuclear Engineering, stated that the agreement combines QLE's fuel cycle expertise with TEES's research capabilities, focusing on collecting fundamental physicochemical data on the reactions involved in producing UF6 from yellowcake uranium (U3O8), a process known as uranium conversion. This work aims to support efforts to improve production technologies, reduce costs, and enhance scalability.
The research is expected to generate data that helps identify opportunities to improve the efficiency of converting U3O8 to UF6, a critical intermediate feedstock in the production of enriched uranium for advanced nuclear energy applications, while supporting process design, modeling, scale-up activities, and optimization of production pathways. Dr. Shao noted that the resulting insights will strengthen the engineering foundation for commercializing QLE's conversion technology, contribute to building a more resilient U.S. nuclear fuel supply chain, and support the cultivation of a stronger nuclear ecosystem in Texas.
By researching scalable and flexible solutions, the agreement is expected to help ensure the availability of fuel resources needed to meet growing nuclear energy demand, enhance energy security, and support the long-term deployment of advanced nuclear technologies. Dr. Shao stated that as countries pursue greater energy independence and accelerate the global energy transition, ensuring material access and strengthening domestic supply chains have become increasingly important, and advancing related technologies requires close collaboration among industry, academia, and government.
As a state agency and part of the Texas A&M University System, TEES's mission is to improve lives through applied research, workforce development, and technology transfer. Dr. Shao said the agreement combines TEES's research capabilities with QLE's uranium conversion commercialization efforts to generate the data and insights needed to support safer, more efficient, and more scalable nuclear fuel production.
ASPI stated in a release that the collaboration between QLE and TEES further demonstrates that industry-led partnerships are driving next-generation nuclear fuel capabilities and solidifying the state's leadership in advanced nuclear energy development. Founded in 2021, ASPI traces its origins back to South Africa's uranium enrichment program in the 1980s. In addition to its subsidiary QLE, ASPI holds a majority stake in PET Labs South Africa, which provides nuclear medicine services in South Africa and sub-Saharan Africa.
